Filter
1234
Text search:
human
pharmaceutical
products
Featured
Recommendations
118
New Publications
332
Language
Document type
No document type
595
Studies & Reports
263
Guidelines
192
Manuals
72
Strategic & Response Plan
69
Training Material
15
Fact sheets
13
Situation Updates
8
Resource Platforms
4
Brochures
2
Infographics
1
Countries / Regions
Kenya
60
Global
51
Ethiopia
40
India
37
Nigeria
27
South Africa
27
Sierra Leone
26
Western and Central Europe
26
Uganda
24
Liberia
23
Rwanda
22
Ghana
21
Namibia
20
Zambia
18
Tanzania
18
Ukraine
17
Philippines
15
Africa
15
Nepal
14
Bangladesh
12
Malawi
12
Latin America and the Carribbean
12
Eastern Europe
12
Zimbabwe
11
Indonesia
11
Lesotho
9
Myanmar / Burma
9
Eswatini/ Swaziland
8
West and Central Africa
7
Burkina Faso
6
Syria
6
Botswana
6
Eastern Europe and Central Asia
6
Asia
6
Cambodia
5
East and Southern Africa
5
Senegal
4
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
South–East Asia Region
4
Guinea
3
Jordan
3
Thailand
3
Mozambique
3
Sudan
3
North Macedonia
3
Venezuela
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
South Sudan
2
China
2
Benin
2
Central African Republic
2
Brazil
2
Middle East and North Africa
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Papua New Guinea
1
Serbia
1
Libya
1
Madagascar
1
Western Pacific Region
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
504
Clinical Guidelines
89
Key Resources
64
Public Health
59
Women & Child Health
33
Pharmacy & Technologies
24
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
159
Pharmacy
130
COVID-19
72
TB
57
HIV
51
Mental Health
46
Planetary Health
38
NTDs
34
Rapid Response
28
Global Health Education
26
Conflict
22
NCDs
22
Caregiver
20
Health Financing Toolbox
19
Ebola & Marburg
17
2.0 Rapid Response
15
Malaria
13
Disability
9
Refugee
7
Specific Hazards
6
Polio
5
Natural Hazards
5
Zika
3
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
The vision of the new Strategic Action Plan for Strengthening HIS in Myanmar 2017- 2021 is “A strong health information system for a strong health system”. The mission statement of HIS in Myanmar also developed during the strategic planning exercise is “Generating and making accessible compreh
...
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community phar
...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva
...
Phytochem Rev (2023) 22:1691–1806
Plants have a lot of potential and will continue to contribute feasible, effective medicines and/or pesticides; more research is warranted to fully explore their future applications
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Accessed: 30.10.2019
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande
...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Global Campaign Against Epilepsy
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi
...
Strengthening health-system emergency preparedness.
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu
...
